SPECIM secures a 3.5 M€ investment by Bocap, strengthens its global market position
/ins. SPECIM, Spectral Imaging Ltd. has agreed to an investment of EUR 3.5 million by Bocap SME Achievers Fund II Ky, with the aim to double its
current 10 M€ revenues by 2020.
Specim is a global pioneer in hyperspectral imaging technology and related products and solutions. Its products are widely used in industrial, environmental and security applications. Specim’s solutions serve mining industries in drill core scanning and producing mineral maps, agriculture to screen the crops for disease and infestation, and they are key components in state-of-the-art waste sorting robotics. Specim’s products also revolutionize the authenticity inspection of artwork, detection of explosives, and forensic investigation.
The miniaturization and fast development of key components and optics enable the development of increasingly powerful and smaller instruments for new applications in food safety, health, cosmetics and many other sectors.
During the past two years, Specim has invested about 6 M€ in developing new generation cameras. It will complete the rollout of a revolutionary new product family by the end of 2017. The products are designed particularly for industrial and professional needs. They offer an easy access to hyperspectral imaging technology for industrial OEM-clients for their own applications. Specim will invest the new funding in further strengthening its position in the global markets.
“I am proud that as a high-tech company Specim will invest nearly as much in sales and marketing as in R&D. With this move it will take full commercial advantage of its superior knowledge, the entire R&D investment, and the new camera family,” explains Specim’s Chairman Risto Kalske, who has brought several high-tech companies into rapid growth.
During Specim’s 22 years of existence, its clientele and customer solutions have gone through a drastic change along with rapidly developing technology. The originally large research equipment weighing tens of kilos and with challenging usability have transformed into compact mobile instruments weighing less than one kilo with revolutionary data processing capabilities. “I have every reason to believe that with miniaturization, hyperspectral imaging will step into people’s everyday lives. Usability will undergo a revolution, and soon mobile equipment can easily be brought to the measurement sites for real-time use. Collecting samples, transporting them to the lab for analysis, and experiencing delays in getting the results will become history,” says Timo Hyvärinen, one of the founders of Specim.
Bocap’s partner, Vilma Torstila, is very excited about this opportunity. “Specim is an excellent company which combines superior technological knowledge with the ability to commercialize it to meet sophisticated and ever-demanding customer needs. We are happy to enhance Specim’s commercial success, and accelerate future growth via this investment.”
SPECIM, Spectral Imaging Oy Ltd. is a leading global developer and supplier of hyperspectral imaging systems, and has delivered more than 5 000 systems worldwide. The company’s core technology team has the world’s longest continuous track record in hyperspectral imaging. Specim is headquartered in Oulu, Finland and employs currently 60 professionals. http://www.specim.fi/
Bocap is an independent private equity company founded in 2012 and dedicated to established, entrepreneur-led, high growth SMEs. It is a forerunner in Finland for its concept and role as an active minority investor, by which Bocap champions its portfolio companies into successful growth. Bocap is funded by mainly Nordic institutional investors such as life and pension insurance companies, foundations, pension funds and selected private investors. http://www.bocap.fi/en
Media Enquiries:
Specim
Risto Kalske, Chairman of the Board
tel. +358 50 368 4054
Bocap
Julianna Borsos, Chair, Founding Partner
tel. +358 50 386 3530
Vilma Torstila, Partner
tel. +358 40 547 4010
vilma@bocap.fi
Let us know if you are going to use this press release. Thank you!